SARASOTA, FL, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug ...
SARASOTA, FL, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery ...
(MENAFN- Investor Brand Network) Silo Pharma (NASDAQ: SILO) , a developmental-stage biopharmaceutical company, has filed a provisional patent application with the U.S. Patent and Trademark Office ...
Silo Pharma (SILO) announced the filing of a provisional patent application with the U.S. Patent and Trademark Office. This application, focused on its lead asset SPC-15, highlights Silo’s commitment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback